Skip to main content

Table 3 Lipid profile

From: Neuropathy-specific alterations in a Mexican population of diabetic patients

  ND DNN DShP DSHP DMN
Triglycerides (mg/dl) 116 (86–159) b 166 (106–203) ab 144 (123–198) a 153 (116–219) a 171 (129–232) a
(N = 363) (N = 20) (N = 109) (N = 50) (N = 40)
Cholesterol (mg/dl) 180 (149–207) a 153 (132–201) a 167 (147–198) a 190 (156–213) a 172 (162–214) a
(N = 363) (N = 20) (N = 109) (N = 50) (N = 40)
HDL-Cholesterol (mg/dl) 46 (38–57) a 42 (38–50) ab 42 (35–50) b 43 (34–53) ab 47 (38–57) ab
(N = 361) (N = 19) (N = 108) (N = 50) (N = 40)
LDL-Cholesterol (mg/dl) 119 (98–140) a 113 (87–148) a 114 (96–138) a 130 (107–159) a 112 (95–132) a
(N = 359) (N = 19) (N = 107) (N = 50) (N = 40)
HDL / LDL 0.39 (0.31–0.51) a 0.39 (0.28–0.53) ab 0.35 (0.30–0.45) ab 0.32 (0.27–0.39) b 0.37 (0.30–0.50) ab
(N = 359) (N = 19) (N = 107) (N = 50) (N = 40)
  1. Different letters indicate statistical differences among groups with a p < 0.05, using a Kruskal-Wallis test with a Dunn post test. Data are represented as median (25th – 75th percentiles of the distribution), and the sample size (N) is shown in the row below. Sample sizes may differ among rows within the same column (group) due to unavailability of individual blood sample for all the measurements